| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-12 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-12 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-11 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.37 | 2e-11 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.32 | 8e-11 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-10 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-09 |